How to Get Rezlidhia (Olutasidenib) Covered by Cigna in Georgia: Appeals, Forms, and Timeline Guide
Quick Answer: Getting Rezlidhia Covered by Cigna in Georgia
Cigna requires prior authorization for Rezlidhia (olutasidenib) with strict criteria: patient must be 18+, have relapsed/refractory AML, and documented IDH1 mutation via FDA-approved test. If denied, you have 180 days to appeal internally, then can request Georgia's external